Elif Altican

Clinical Operations in EMEA: The Strategic Role of Contract Staff 🌍💡 In today's fast-paced pharmaceutical landscape, agility is paramount, especially within Clinical Operations across Europe, the Middle East, and Africa (EMEA). As pipelines burgeon and regulatory frameworks evolve, the demand for specialised talent surges. Here's where contract staff becomes a game-changer. 👨‍🔬 Contract professionals provide the flexibility needed to navigate the complexities of clinical trials. With their focused expertise, they can hit the ground running, driving projects forward without the long lead times of permanent hires. In an industry where time is of the essence, this agility can be the difference between success and delay. 🔍 The benefits are multifold: adaptability in scaling team sizes, access to niche skill sets, and the ability to manage the ebb and flow of project demands. Furthermore, contract staffing avoids the long-term commitments of full-time employment, optimising operational costs and enabling a dynamic response to market shifts. Embracing contract staffing is not just about filling gaps; it's about strategic resourcing to enhance capability and competitiveness in the EMEA region. Have you experienced the impact of contract professionals in your Clinical Operations? Let's discuss how this model is shaping the future of our industry. #ClinicalOperations #ContractStaffing #EMEA #Science #HRS

17

🚀 Big Pharma Boosts Investment in France! Sanofi, Pfizer, GSK and AstraZeneca are ramping up their commitment to France with nearly €2 billion in investments! Here's the breakdown: 💼 Sanofi Leads the Charge: Investing over €1 billion to expand biologics production, doubling capacity in Vitry-sur-Seine and injecting €100 million into the Le Trait site in Normandy. 🔬 Pfizer's Push: Allocating €500 million to bolster R&D and clinical trials, focusing on sickle cell disease and multiple myeloma, while also enhancing manufacturing capabilities. 💊 AstraZeneca's Expansion: Injecting €360 million into its manufacturing facility in Dunkirk, specializing in inhaled devices, to further support its operations and workforce. GSK is set to unveil new investments in the country later this week. These investments not only drive innovation and growth but also underscore France's attractiveness for global pharma players. #Pharma #Executivesearch #France

16

1 commentaire

Making Strides: Clinical Research in Europe, the Middle East, and Africa In the world of clinical research, things are always changing, especially in Europe, the Middle East, and Africa. Lately, there's been a lot of excitement about using new tech and keeping up with changes in rules to improve future medical studies. A big change is how we're now doing clinical studies - we're using tech to do them in ways that fit better into people's lives. This means more people can join these studies, which is great for everyone. New rules from the European Medicines Agency also mean that we focus more on keeping patients safe and making sure research data is solid. Everyone likes this because it means we're being more open and doing things the right way. The UK's Medicines and Healthcare products Regulatory Agency has put forward some ideas, which are still being discussed, to help make our region better at doing research. These ideas should make it easier to start studies, encourage new ways of doing things, and keep everyone taking part safe. So, all in all, our part of the world is really pushing ahead with new ideas in clinical research. Every step forward not only helps medicine itself but also improves how patients feel about their treatment and gets new treatments to people faster. By working together and focusing on technology and patients, we're keeping our region at the forefront of global clinical research. #ClinicalOperations #EMEA #HealthTech

6

Project Optimus is revolutionizing early oncology trials, aiming to ensure more effective and safer cancer drugs and improve patients' quality of life. Parexel experts have identified three strategies to help sponsors overcome challenges in achieving dose-optimization requirements. Here’s what we know works: 1️⃣ Design an integrated first-in-human study 2️⃣ Reach agreement with FDA at each step 3️⃣ Challenge guidelines with a compelling rationale Let me know your thoughts below and read more in our New Medicines, Novel Insights report! https://lnkd.in/gGq8kYeY #ProjectOptimus #Oncology #NovelInsights

8

Sanofi reports that it has invested more than €1 billion ($1.1 billion) in Bioproduction in France across 3 sites! The new investment is expected to create more than 500 jobs and strengthen France’s ability to control the production of essential medicines from start to finish, currently and into the future, according to the company. The company will invest €1 billion to build a new facility in Vitry-sur-Seine that will double the site’s monoclonal antibody production capacity. Several biologics in development, including those for chronic obstructive pulmonary disorder (COPD), asthma, multiple sclerosis, and type 1 diabetes, could be produced in Vitry. At the Le Trait site in Normandy, Sanofi will invest €100 million ($109 million) to develop new capacity for biologics formulation, filling, device assembly and packaging. It will support the launch of future biologics and vaccines, as well as for the growth of Dupixent®, which already is indicated in several inflammatory diseases and could soon become the first biologic indicated in COPD, notes a Sanofi official. In Lyon Gerland, Sanofi is investing €10 million ($10.9 million) to locate the production of TZield® in France. Tzield is a biologic for type 1 diabetes that Sanofi acquired in April 2023 and which has been manufactured outside Europe. This plan brings to more than €3.5 billion ($3.8 billion) the amount committed by Sanofi since the COVID-19 pandemic in major projects to keep production of medicines and vaccines in France.

16

🌟 Embracing Leadership Evolution in the Life Sciences Industry 🌟 As we navigate the dynamic landscape of the Life Sciences industry, one thing becomes abundantly clear: the impact of visionary leaders is profound. We've witnessed a surge of transformative leaders who embody qualities crucial for success: a positive and optimistic mindset, a dedication to empowering their teams, a genuine concern for individual growth, leading by example, and a willingness to embrace challenges from peers and employees alike. These leaders understand that fostering a culture of empowerment not only drives innovation but also cultivates a sense of purpose within their teams. They recognize that true leadership isn't about control, but rather about collaboration and support. However, it's equally important to acknowledge the outdated mindset of traditional "bosses" who cling to micromanagement and hierarchical structures. In today's fast-paced world, this approach stifles creativity and limits potential. Let's champion a new era of leadership in Life Sciences—one that celebrates innovation, fosters growth, and empowers individuals to reach their full potential. Together, we can shape a brighter future for our industry and beyond. #LeadershipEvolution #LifeSciences #Empowerment #Innovation 🚀

6

Exciting news! Please tune in to this panel discussion on tackling AMR at Swiss Biotech Day, with esteemed experts coming together to address this critical global challenge and discuss actionable steps for the fight against AMR.

4

🌟 Are you leading clinical operations in Europe? 🇪🇺 Let's talk about staffing needs! 🌱 As the landscape of clinical operations continues to evolve, ensuring the right team is in place is crucial. From keeping up with regulatory changes to maximizing efficiency, having the right staff can make all the difference. What are the key roles you find essential in your team? 🤔 How do you navigate recruitment challenges in such a competitive market? 💼 And, most importantly, how do you ensure your team stays motivated and engaged? 🚀 Let's spark a discussion! Share your insights and experiences in the comments below. Your expertise could inspire others in our community. 🔍💡💬 #ClinicalOperations #StaffingNeeds #EuropeanHealthcare #Science #HRS

7

1 commentaire

🌍 The European clinical trials landscape is evolving rapidly, and with it, the demand for agile and skilled freelance staff is surging. Here's why: In the fast-paced world of clinical research, adaptability is key. Freelancers offer a level of flexibility that is invaluable for projects with fluctuating workloads and tight deadlines. They can be brought on board to manage specific tasks or to provide expertise in niche areas, ensuring that the trial progresses efficiently without the need for long-term commitments. Moreover, the diverse nature of clinical trials across Europe, with its myriad of regulations and languages, calls for a workforce that is not only knowledgeable but also culturally adept. Freelancers from various backgrounds bring this cultural competence to the table, along with the ability to navigate the regulatory nuances of different European countries. The rise of remote work has further amplified the feasibility of engaging freelance staff. With the ability to work from anywhere, freelancers can contribute to clinical trials without the constraints of location, allowing for a more diverse and skilled talent pool to be tapped into. In essence, the freelance revolution is reshaping the clinical trials domain in Europe. It's a win-win: trials can progress with more agility and efficiency, while freelancers enjoy the autonomy and diversity of projects that enrich their professional experience. #ClinicalTrials #FreelanceRevolution #EuropeanHealthcare #HRS #Science

17

📢Unlock the future of Oncology in the Middle East & Africa 🔑Key findings: 🔬Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, potentially increasing by more than 12 million new cases annually to 32 million. 💸Global spending on cancer medicine increased to $223 billion in 2023, $25 billion more than 2022, and is projected to reach $409 billion by 2028. 💊In 2023, 25 oncology novel active substances (NASs) were launched globally, making a total of 193 since 2014 – however, large geographic variations exist in availability of these medicines. 🧪More than 2,000 new oncology clinical trials started in 2023 with novel modalities and significant promise for cancer treatment, including cell and gene therapies, antibody-drug conjugates, multispecific antibodies, and radioligand therapies. 💉Cancer treatments have increased 9% annually since 2019 but the pace of bringing novel therapies to patients is uneven due to differences in biomarker testing rates, adoption of novel therapies and lack of infrastructure capacity to deliver some of the most advanced therapies. Aspire Life Sciences Search Aspire Recruitment Group IQVIA #lifesciences #oncology #cancer #therapies #mea

9

Hiring alert for CROs! 🚨 Struggling to navigate the ever-evolving clinical talent pool? Let's streamline your talent acquisition! At our Hyper Recruitment Solutions, we're equipped with a deep grasp of the EMEA market and an agile roster of clinical research professionals ready to join your team on contract. We understand the dynamic backdrop of clinical trials and the critical need for top-tier expertise. By partnering with us, you gain access to adept contract staff who can seamlessly integrate into your projects, adding value from day one. Our meticulous vetting process ensures candidates don't just fit the role technically, but are also aligned with your organizational culture and values. Let's connect to discuss how we can fortify your clinical research endeavors - it's time to turn hurdles into stepping stones for success. Drop a like, comment below, or simply share this post within your network to spread the word. #ClinicalResearch #LifeScienceRecruitment #TalentAcquisition #HRS #Science

11

Key Insights on Medical Directors in Pharma and Biotech As we explore the changing landscape of the pharmaceutical and biotech industries, I've discovered ten crucial insights from the latest talent report that highlight the role of Medical Directors. Here's what you should know: 1. Total Talent Pool: 6,691 professionals are actively shaping this field, including 3,714 Medical Directors, 1,581 Senior Medical Directors, and 1,396 Associate Medical Directors. 2. High Demand: Medical Directors are in great demand, with total job postings exceeding job changes by 31%. 3. Gender Diversity: The talent pool shows nearly perfect gender balance, with 51% female and 49% male professionals. 4. Compensation Insights: The average base salary is a strong $285,200, ranging from $195,000 to $432,000, emphasizing promising career opportunities. 5. Education Leaders: Rutgers University and Harvard Medical School lead in educational excellence, producing 178 and 160 graduates, respectively. 6. Tenure and Turnover: The median tenure in current roles is 2.6 years, suggesting a dynamic career path within the industry. 7. Hidden Gem Locations: Talent hotspots include Greater Philadelphia, Greater Chicago, and Los Angeles — important areas for recruitment and growth. 8. Employer Value Propositions: A remarkable 87% of professionals agree that excellent compensation and benefits are essential, making them key factors in employer appeal. 9. Top Employers: Pfizer leads with 459 Medical Directors, closely followed by industry leaders like AbbVie and Amgen. 10. Top Cities for Talent: New York City, Greater Boston, and the San Francisco Bay Area stand out as top cities with the most Medical Directors. Stay tuned for Part 2 next week for a deeper analysis! #MedicalDirectors #Pharma #Biotech #TalentManagement #CareerInsights #ProfessionalGrowth

7

🌟 Seeking Biotech Trailblazers! 🌟 Are you at the forefront of Biotech innovation, pushing the boundaries of Clinical Operations in Europe? Your groundbreaking work deserves the best talent to propel it forward. That's where we come in. 🔍 We specialize in contract staffing, providing you with the agile workforce you need to navigate the dynamic landscape of Clinical Operations. Our candidates are not just skilled; they're innovators, thinkers, and the driving force behind the next wave of biotechnological breakthroughs. 🌐 With a vast network across Europe, we understand the unique challenges and opportunities within the biotech sector. We're not just recruiters; we're your strategic partners, dedicated to ensuring your projects are powered by professionals who can hit the ground running. 💡 Imagine a staffing solution that's as flexible and cutting-edge as you are. Whether it's short-term assignments or project-based needs, we tailor our services to fit your unique objectives. Let's collaborate to build a future where your projects are staffed with the brightest minds in Clinical Operations. Connect with us to explore how we can fulfill your contract staffing needs with precision and speed. #BiotechInnovation #ClinicalOperations #StaffingSolutions #HRS #Science

9

Really interested to see how AstraZeneca will achieve these ambitious goals of delivering $80bn in annual revenue by 2030! Just for context: - 75% higher than what it raked in last year at $45.8 billion - More than 8% YoY growth will need to be acheived (GSK, Johnson & Johnson & Novartis aiming for 5-7%) - Patent Expiration - Farxiga, Lynparza, Tagrisso and Calquence - Restructuring across their #UK sites With more than 170 programs in its pipeline and potentially more acquisitions on the horizon, will we be standing here in 2030 celebrating with AZ? #Pharmaceutical #Growth #Biotech

10

🌍 Seeking Clinical Operations Talent Across Europe? 🌟 Are you a Clinical Research Organization (CRO) navigating the complex terrain of clinical trials? Finding the right freelance Clinical Operations staff can be the keystone to your project's success. Here's why partnering with seasoned freelancers could be your strategic advantage: 🔍 Flexibility & Expertise: Freelancers offer unparalleled flexibility, adapting to the ebb and flow of your project needs. They bring a wealth of expertise from diverse backgrounds, injecting fresh perspectives into your operations. 📈 Cost-Effective Solutions: With freelancers, you pay for the expertise when you need it, without the overheads associated with full-time staff. This means you can allocate resources more efficiently, scaling your team in alignment with project demands. 🤝 Partnership & Growth: Freelancers are more than temporary hires; they're potential long-term partners. By building a network of trusted freelance professionals, you're investing in a pool of talent that can support your growth across Europe. I'm on a mission to connect CROs with top-tier Clinical Operations freelancers. Whether it's for a pivotal phase III trial or a series of smaller studies, my network spans the continent, ready to step in and drive your research forward. If you're looking to enhance your clinical trial operations with skilled freelancers, let's talk. Drop a comment, send a message, or simply hit 'like' to signal your interest. Let's revolutionize the way we staff clinical research - together. #ClinicalResearch #FreelanceTalent #ClinicalOperations #CRO #EuropeanTalent

19

#FreelanceStaff #ClinicalTrials #Europe In Europe's dynamic Clinical Trials space, the demand for Freelance Staff is rapidly escalating. 🌟 From navigating regulatory nuances to ensuring trial integrity, freelance professionals bring unparalleled expertise and flexibility to the table. 💼 As trials evolve, the need for specialized skills grows, making freelancers a pivotal resource. Let's collaborate and elevate clinical research together! 💬 #ClinicalResearch #IndependentExperts #InnovateEurope #HRS #Science

22

1 commentaire

Curious about the power of AI in global clinical trials? 🤖 Don’t miss the session by Stephane Millet and Kathleen O'Brien at #OCTEastCoast ! Together, they'll share real-life AI applications and insights to support global patient recruitment 🚀 Session details: 🔍 Topic: "Innovations in Patient Recruitment, powered by AI" 🗓️ Date: May 21 ⏰ Time: 12:45 PM Learn more about the session and event here: https://lnkd.in/dHVS5eH6 #Acolad #AI #ClinicalTrials #LifeSciences

41

Curious about the future of Medical Affairs in EMEA (Europe, Middle east and Africa)? Get ready to dive into the heart of innovation and collaboration at MAPS EMEA 2024 Annual meeting!   Join us as Charlotte Kremer MD MBA, CMO of MAPS, shares her insights on what's in store for this year's conference in Madrid. Here's a sneak peek at what she has to say:   What's the Focus of MAPS EMEA 2024? Why will Medical Affairs improve with THIS Conference? How can we do things differently AFTER the Conference?   Ready to take your career to new heights? Join us at MAPS EMEA Conference from May 12th to 14th in Madrid! Connect with like-minded professionals, learn from thought leaders, and be part of shaping the future of Medical Affairs.     MAPS Iberia (Spain/Portugal) Chapter   #MAPSEMEA24 #MedicalAffairs #MedAffairs #MAPSEvent #Innovation #HealthcareRevolution #Jointhemovement

72

Navigating the Complex Terrain of Staffing in European Clinical Operations 🌍💼 In the ever-evolving landscape of clinical trials, the right staffing strategy is not just an advantage; it's a necessity. As Clinical Operations Directors, we're at the helm of this dynamic environment, steering through the unique challenges of European regulations and diverse talent pools. But how do we ensure that our teams are not just filled, but are composed of the right calibre of professionals to drive success? The first step is often understanding the pulse of the industry. With the rise of virtual trials and decentralized approaches, are we adapting our hiring strategies to meet these new demands? Are we investing in training to bridge the gap between traditional methods and innovative technologies? But it's not just about the 'what' and 'how'—it's also about the 'who.' The cultural diversity within Europe adds layers of complexity to our operations. Are we leveraging this diversity to enhance our teams' performance, or is it an underutilized asset in our staffing strategy? As we delve into the talent acquisition maze, we're faced with questions like: How do we maintain a balance between experience and fresh perspectives? Are we too focused on qualifications over potential, or vice versa? Let's talk about flexibility and its role in retention and satisfaction. Are our staffing models agile enough to accommodate the changing needs and preferences of top-tier professionals? How are we ensuring that our work environments remain attractive to the best in the field? I'm keen to hear your thoughts and strategies. How are you tackling these staffing challenges in your corner of Europe? What innovative approaches have you found effective in building and sustaining high-performing clinical operations teams? #ClinicalOperations #StaffingStrategies #EuropeanTalent #ClinicalTrials

11

1 commentaire